Fees are a weakness here. The strategy's lofty fees are a high hurdle to clear, as it is priced within the most expensive quintile among peers.
Morgan Stanley Inst Corporate Bond A MIGAX Fund Analysis
Morningstar’s Analysis MIGAX
Will MIGAX outperform in future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar